Flow‐Cytometric Guidance of High‐Dose Anti‐D Prophylaxis in Massive Fetomaternal Hemorrhage: A Case Report
International Journal of Laboratory Hematology · 2026-12 · 48 (6) · 1538-1542
DOI: 10.1111/ijlh.70169 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 09.06.2026. Verfasst von William P T M van Doorn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry, Central Diagnostic Laboratory, Maastricht University Medical Center+, Maastricht, the Netherlands. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Clinical Chemistry, Central Diagnostic Laboratory, Maastricht University Medical Center+, Maastricht, the Netherlands.
- Department of Obstetrics and Gynaecology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.
- School of Health Professions Education, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.
Zitieren
APA
van Doorn, W. P. T. M., Zandstra, H., Teunissen, P. W., & de Wit, N. C. J. (2026). Flow‐Cytometric Guidance of High‐Dose Anti‐D Prophylaxis in Massive Fetomaternal Hemorrhage: A Case Report. International Journal of Laboratory Hematology, 48(6), 1538-1542. https://doi.org/10.1111/ijlh.70169
Vancouver
van Doorn WPTM, Zandstra H, Teunissen PW, de Wit NCJ. Flow‐Cytometric Guidance of High‐Dose Anti‐D Prophylaxis in Massive Fetomaternal Hemorrhage: A Case Report. International Journal of Laboratory Hematology. 2026;48(6):1538-1542. doi:10.1111/ijlh.70169
BibTeX
@article{vanDoorn2026,
author = {van Doorn, William P T M and Zandstra, Heleen and Teunissen, Pim W and de Wit, Norbert C J},
title = {Flow‐Cytometric Guidance of High‐Dose Anti‐D Prophylaxis in Massive Fetomaternal Hemorrhage: A Case Report},
journal = {International Journal of Laboratory Hematology},
year = {2026},
volume = {48},
number = {6},
pages = {1538--1542},
doi = {10.1111/ijlh.70169}
}
EUVIMED